In 2025, Mubadala will continue its efforts to strengthen the national economy, create quality job opportunities to support national talent, attract global capital, and accelerate the growth of strategic sectors that support the long-term competitiveness of the national economy. The investment sector in the UAE has strengthened its leading role in driving economic diversification and achieving the desired value at the national level. Mubadala contributed 45 billion dirhams to the GDP, equivalent to 5.7% of the non-oil GDP of the Emirate of Abu Dhabi, while supporting around 98,000 quality jobs in Abu Dhabi directly and indirectly, an increase of 51% since 2021, which reinforces Mubadala's role and efforts in empowering and developing national talent. Companies 'Al Dar' and 'Mubadala Capital' launched the 'Al Dar Capital' platform, an investment platform that connects global investors with opportunities in physical assets across Gulf Cooperation Council countries. 'Al Dar Capital' is based in 'Abu Dhabi Global', and it provides global institutional investors with opportunities to invest in professionally managed physical assets, with its first fund targeting to raise $1 billion (3.7 billion dirhams) by 2026. The company 'Mubadala Bio', a national leading company in the life sciences sector, was also launched, aiming to solidify the UAE's capabilities in the biopharmaceutical sector through 10 world-class facilities. In 2025, the company began the local production of eight essential medicines, contributing to improving access to critical biologic therapies, enhancing national pharmaceutical security, and developing a sustainable life sciences ecosystem in the UAE. Emirates Global Aluminium also continues its progress by developing an aluminum smelter in the US, the first of its kind in decades, alongside advanced smelting technologies. Additionally, a mega-project for the expansion of the financial center on Al Maryah Island in Abu Dhabi, valued at over 60 billion dirhams, was announced in partnership with 'Al Dar', reaffirming Abu Dhabi's status as the 'capital of capital'. The company 'M42' launched an advanced program in collaboration with 'Oracle Health' to create a unified and easily accessible national patient health record system, integrating data from the UAE Genome Program into electronic health records to support genomics-based drug recommendations. The company 'Masdar' also announced the groundbreaking for the world's largest renewable energy project, combining solar power and battery storage, with a 24/7 renewable energy generation capacity of 1 GW, in partnership with 'Emirates Water and Electricity'.
